The authors assessed the biodistribution, tumor-targeting properties, and in vivo deiodination of both directly and indirectly 125I-labeled, anti-CD105 monoclonal antibodies (mAbs) in mice bearing murine melanoma cell line B16F10. This evidence concerns the gene ENG and melanoma.